Translate this page into:
Nasal lesions in dermatology: A comprehensive clinico-syndromic and morphological guide with emerging entities
-
Received: ,
Accepted: ,
How to cite this article: Krishnamurthy SD, Yuvaraj BY, Thippeswamy V. Nasal lesions in dermatology: A comprehensive clinico-syndromic and morphological guide with emerging entities. CosmoDerma. 2026;6:66. doi: 10.25259/CSDM_42_2026
INTRODUCTION
The nose represents a unique and clinically significant cutaneous region where dermatological conditions frequently manifest with distinct patterns and diagnostic implications. Owing to its exposed position, specialized skin characteristics, and high density of sebaceous units, the nasal skin is prone to a broad spectrum of disorders ranging from inflammatory and vascular dermatoses to benign and malignant tumors, often challenging both diagnosis and management.[1,2] In addition, continuous exposure to ultraviolet radiation, environmental pollutants, and minor repetitive trauma further contributes to the susceptibility of this region to both acute and chronic dermatoses. Its central facial location further amplifies cosmetic visibility and psychosocial impact, making early recognition and appropriate intervention crucial.[2]
Specific conditions such as rhinophyma, a phymatous variant of rosacea, underscore the interplay between chronic inflammation, vascular dysregulation, and connective tissue remodeling in nasal skin pathology.[3,4] The progression from transient erythema to fixed tissue hypertrophy reflects a spectrum of disease severity that may be modified by early therapeutic intervention. The nose may also serve as an early sentinel site for systemic disease, including violaceous plaques in sarcoidosis and destructive midline lesions in granulomatosis with polyangiitis.[5,6] In many cases, nasal involvement precedes systemic manifestations, thereby offering a critical window for early diagnosis. Recognition of such findings often enables earlier systemic evaluation and improved prognostic outcomes.
This review adopts a structured, pattern-based approach to nasal dermatoses, integrating anatomical relevance, deformities, inflammatory and infectious disorders, neoplasms, syndromic associations, systemic diagnostic clues, procedural dermatology, psychosocial aspects, and recently emerging entities, thereby providing a comprehensive clinical framework for dermatologists.
ANATOMICAL LANDMARKS AND SURGICAL RELEVANCE
The nasal tip and alae contain thick sebaceous skin with dense pilosebaceous units, whereas the dorsum possesses relatively sparse subcutaneous tissue and thinner coverage over osteocartilaginous structures.[7] This anatomical variation explains the differential distribution of acneiform disorders, vascular lesions, and scarring tendencies across nasal subunits. Furthermore, variations in lymphatic drainage influence the spread of infections and neoplastic cells.
A rich superficial and deep vascular plexus contributes to prominent erythema, rapid wound healing, and increased intraoperative bleeding risk. Knowledge of angular and dorsal nasal arterial anatomy is critical during filler injections and flap reconstruction to prevent ischemic necrosis or visual compromise.[8,9] In addition, the presence of end-arterial circulation in certain zones increases vulnerability to vascular occlusion during cosmetic procedures.
Understanding nasal esthetic subunits and structural support zones, such as the keystone area, guides reconstructive planning and optimizes cosmetic outcomes [Table 1].[7] Consideration of relaxed skin tension lines and subunit replacement principles further enhances surgical precision and esthetic integration.
| Anatomical landmark | Clinical significance |
|---|---|
| Angular and dorsal nasal arteries | Critical for fillers/flaps; occlusion→necrosis, blindness |
| Dangerous area of the face | Retrograde spread→cavernous sinus thrombosis |
| Internal nasal valve | Narrowest airway; key to airflow obstruction |
| K-area (Keystone area) | Dorsal stability; disruption→saddle nose |
| Nasal tip | End-arterial zone; high ischemic risk in procedures |
| Soft triangle of converse | No cartilage; prone to notching/scarring |
| Nasal vestibule | Common site for infections (furunculosis and vestibulitis) |
| Cosmetic subunits | Guide reconstruction for optimal esthetic outcome |
| Sun terrace | High UV exposure; prone to skin cancers |
| T-zone | Sebaceous-rich: acne, rosacea, seborrheic dermatitis |
UV: Ultraviolet
CONGENITAL AND ACQUIRED NASAL DEFORMITIES
Congenital nasal deformities often reflect embryologic disruption or genetic syndromes and may serve as early phenotypic markers of systemic disease.[10] Associated anomalies involving craniofacial structures, the central nervous system, or the airway may coexist and warrant comprehensive evaluation. Structural abnormalities such as saddle nose, bifid nose, or hypoplastic alae require multidisciplinary evaluation and long-term follow-up.
Acquired deformities commonly arise from trauma, infection, granulomatous inflammation, vasculitis, substance abuse, or neoplasia.[5,6] Chronic inflammatory destruction may lead to irreversible cartilage loss and functional impairment. Midline destruction should raise suspicion for autoimmune or infiltrative pathology. Early recognition facilitates timely intervention and improves reconstructive outcomes [Table 2].
| Deformity | Key features | Clinical association |
|---|---|---|
| Saddle nose | Depressed bridge | GPA, leprosy, syphilis, cocaine |
| Rhinophyma (potato nose) | Bulbous fibrotic tip | Chronic rosacea |
| Clown nose deformity | Red nodular tip | Cutaneous metastasis |
| Cocaine nose | Septal perforation | Cocaine abuse |
| Gummatous nose | Ulcer+collapse | Tertiary syphilis |
| Strawberry nose | Granular erythema | Sarcoidosis |
| Tapir nose | Shrinking with crusting | Leishmaniasis |
| Bulldog facies | Depressed bridge | Congenital syphilis |
| Binder syndrome | Flat bridge, midface hypoplasia | Congenital |
| Bifid nose | Midline cleft | Frontonasal dysplasia |
GPA: Granulomatosis with polyangiitis
SEBACEOUS GLAND DISORDERS
The sebaceous richness of the nasal tip and alae predisposes to acne vulgaris, sebaceous hyperplasia, and phymatous change.[3] Increased sebaceous activity, altered keratinization, microbial colonization, and chronic inflammation contribute to the characteristic morphology of nasal lesions. Hormonal influences and environmental triggers may further modulate disease expression.
Rhinophyma represents advanced tissue hypertrophy with nodular thickening and fibrosis, typically developing in longstanding rosacea.[4] Progressive enlargement may lead to functional obstruction and significant cosmetic disfigurement. Early medical management may prevent irreversible deformity [Figure 1].

Sebaceous tumors occurring on the nose may act as cutaneous markers of Muir–Torre syndrome, prompting evaluation for internal malignancy.[11] Recognition of such lesions is crucial for initiating appropriate oncologic screening.
VASCULAR AND NEUROVASCULAR DISORDERS
Persistent centrofacial erythema and telangiectasia are hallmark features of rosacea and photodamage.[3,4] Flushing episodes may be triggered by thermal, dietary, or emotional stimuli, reflecting underlying neurovascular dysregulation. Differentiating vascular instability from inflammatory infiltration is essential for targeted therapy [Figure 2].

Nasal vascular changes may also indicate connective tissue diseases or vasculitic processes.[6] The presence of purpura, ulceration, or necrosis warrants urgent systemic evaluation. Early identification of vascular compromise can prevent tissue loss and systemic complications.
Dermoscopic and histopathologic correlation enhances diagnostic precision in ambiguous presentations.[12] Emerging imaging modalities such as high-frequency ultrasound may further aid in assessment.
INFECTIVE DERMATOSES
The nose frequently acts as a reservoir and sentinel site for cutaneous infections due to colonization of the anterior nares.[13] This colonization predisposes to recurrent infections and autoinoculation. Impetigo, folliculitis, and vestibulitis commonly arise in this region.
Chronic ulcerative or infiltrative lesions should raise suspicion for cutaneous leishmaniasis, lupus vulgaris, or leprosy.[14] Secondary bacterial infection may complicate these conditions, accelerating tissue destruction. Delay in diagnosis may result in cartilage destruction and disfigurement. Early microbiologic confirmation and targeted therapy are essential to prevent complications [Figures 3-6].




GRANULOMATOUS DISORDERS
Granulomatous plaques and nodules over the nose often represent early manifestations of systemic inflammatory disease. Lupus pernio is a classic cutaneous sign of sarcoidosis.[5] Such lesions are often chronic and resistant to therapy, reflecting underlying systemic involvement.
Saddle-nose deformity and destructive ulceration may indicate underlying vasculitis such as granulomatosis with polyangiitis.[6] Biopsy and serologic testing are essential for differentiation. Prompt recognition prevents progressive tissue loss and systemic morbidity.
NEOPLASTIC AND PREMALIGNANT CONDITIONS
The nose is a high-risk anatomical site for cutaneous malignancy due to cumulative ultraviolet exposure and thin dermal support. Basal cell carcinoma and squamous cell carcinoma frequently occur on the nasal dorsum and tip.[15,16] Delayed diagnosis may result in deeper invasion and complex reconstruction.
Actinic keratoses represent premalignant lesions that reflect field cancerization and require surveillance or intervention.[17] Dermoscopy aids early detection of subtle malignant changes.[12] Non-invasive imaging techniques are increasingly used for early diagnosis. Timely excision with tissue-sparing techniques preserves both function and cosmesis [Figures 7-9].[18]



GENODERMATOSES AND SYNDROMIC ASSOCIATIONS
Characteristic nasal lesions may provide early diagnostic clues to inherited disorders. Angiofibromas on the nasal tip may suggest tuberous sclerosis complex [Figure 10] while multiple basal cell carcinomas raise suspicion for Gorlin syndrome.[19] Additional cutaneous markers may coexist and assist in syndromic diagnosis.

Recognition of pigmentary or sebaceous abnormalities over the nose should prompt systemic screening and genetic counseling when appropriate [Table 3]. Early identification allows surveillance for associated neurologic, renal, or skeletal complications and improves long-term outcomes.
| Syndrome | Nasal feature | Clinical significance |
|---|---|---|
| Tuberous sclerosis | Angiofibromas | Early diagnosis; CNS/renal screening |
| Basal cell nevus syndrome | Multiple BCCs | Requires surveillance |
| Muir–Torre syndrome | Sebaceous tumors | Internal malignancy marker |
| Leopard syndrome | Pigmented macules | Cardiac/systemic screening |
CNS: Central nervous system, BCCs: Basal cell carcinomas
NOSE AS A DIAGNOSTIC CLUE IN SYSTEMIC DISEASE
The nose frequently reveals early markers of systemic illness through characteristic patterns such as malar erythema, ulceration, necrosis, or infiltrative plaques.[6,20] Subtle clinical signs may precede laboratory abnormalities, emphasizing the importance of careful inspection.
For example, butterfly rash over the nasal bridge is strongly associated with systemic lupus erythematosus [Figure 11], while destructive midline lesions warrant evaluation for vasculitis or malignancy. Recognition of classical named nasal signs enhances bedside diagnostic accuracy and guides focused systemic assessment [Table 4].
| Sign | Key feature | Association |
|---|---|---|
| Butterfly rash | Malar erythema | SLE |
| Lupus pernio | Violaceous plaques | Sarcoidosis |
| Hutchinson’s sign | Vesicles on the tip | Herpes zoster (ocular risk) |
| Saddle nose | Depressed bridge | GPA, infections |
| Nasal necrosis | Black eschar | Mucormycosis, vasculitis |
| Apple-jelly nodules | Yellow-brown on diascopy | Lupus vulgaris |
| Clown nose sign | Red nodular lesion | Metastasis |
| Nasal telangiectasia | Dilated vessels | Rosacea, CREST |
| Allergic salute | Transverse crease | Allergic rhinitis |
SLE: Systemic lupus erythematosus, GPA: Granulomatosis with polyangiitis, CREST: Calcinosis cutis Raynaud’s phenomenon Esophageal dysmotility Sclerodactyly Telangiectasia

PROCEDURAL DERMATOLOGY
Procedures involving the nose require meticulous anatomical knowledge due to the complex vascular supply and esthetic prominence. Laser therapy for telangiectasia must be carefully titrated to minimize scarring and dyspigmentation.[3] Patient selection and parameter optimization are essential for safe outcomes.
Injectable fillers carry the risk of vascular occlusion and vision loss; therefore, slow injection techniques and awareness of arterial pathways are essential.[8,9] Use of cannulas and aspiration techniques may further reduce complications. Mohs micrographic surgery remains the gold standard for high-risk non-melanoma skin cancers, ensuring complete margin control with maximal tissue preservation.[18]
PSYCHOSOCIAL AND COSMETIC CONSIDERATIONS
Nasal dermatoses significantly influence self-esteem, interpersonal interactions, and overall quality of life.[2] Even minor lesions may produce disproportionate psychological distress because of facial centrality. Cultural perceptions of facial appearance may further influence patient concerns and treatment expectations.
Holistic management should address both medical treatment and cosmetic rehabilitation, including counseling and, when appropriate, camouflage techniques to optimize long-term outcomes.
EMERGING AND RECLASSIFIED NASAL DERMATOSES
Recent advances have expanded the spectrum of inflammatory, infectious, and autoinflammatory disorders affecting the nose. Improved molecular diagnostics have enabled the identification of novel genetic and immune-mediated conditions.[3] Advances in dermoscopy, imaging, and molecular pathology are refining diagnostic accuracy.
Ongoing research continues to refine classification and management strategies [Table 5], with increasing emphasis on personalized and targeted therapeutic approaches [Figure 12].
| Entity | Key nasal feature | Pathomechanism | Clinical significance |
|---|---|---|---|
| Lichenoid pseudovesicular papular eruption | Tiny translucent papules | Lichenoid interface dermatitis | Mimics vesicular disorders; differentiates from LMDF/rosacea |
| Midline lethal granuloma (NK/T-cell lymphoma, nasal type – NKTCL) | Progressive ulceration, destruction | EBV-associated angiocentric lymphoma | Aggressive; early biopsy essential |
| Neutrophilic dermatosis of the nasal tip | Painful swollen nasal tip | Neutrophilic infiltrate | Steroid responsive |
| Lipin-1-associated inflammatory panniculitis (LPIN1 disease) | Recurrent nasal/facial nodules | Metabolic lobular panniculitis | Systemic metabolic clue |
| Majeed syndrome (LPIN2-related disease) | Sterile neutrophilic plaques | IL-1-mediated autoinflammation | Systemic autoinflammatory disorder |
| IgG4-related disease | Rhinophyma-like induration | Storiform fibrosis, IgG4 plasma cells | Steroid-responsive systemic disease |
| COVID-associated pernio-like lesions | Violaceous nasal plaques | Interferon-mediated vascular injury | Post-COVID-19 self-limited lesion |
| Pseudoacne of the nasal crease | Acne-like papules | Keratin granulomatous reaction | Acne-resistant condition |
| Elastosis linearis rubra nasi | Linear erythematous lesions | Dermal elastosis | Cosmetic relevance |
| Trigeminal trophic syndrome | Unilateral nasal ulcer | Neurogenic self-inflicted ulceration | Neuropathic origin |
| VEXAS syndrome | Neutrophilic nasal lesions | UBA1 somatic mutation | Severe adult autoinflammatory disease |
| Granulosis rubra nasi | Nasal erythema, sweating | Eccrine dysfunction | Pediatric/adult variant described |
| Morbihan disease | Solid facial/nasal edema | Lymphatic obstruction | Resistant rosacea variant |
| Trichodysplasia spinulosa | Follicular spicules | Polyomavirus infection | Immunosuppression marker |
| Cocaine-induced nasal dermatosis | Necrosis, crusting | Vasculopathy, levamisole toxicity | GPA/lymphoma mimic |
| CANDLE syndrome | Perinasal nodules | Proteasome dysfunction | Pediatric autoinflammatory disease |
| Acquired dermal melanocytosis of the nose | Blue-gray pigmentation | Dermal melanocytes | Laser responsive |
| Post-COVID nasal vasculopathy | Ischemic necrosis | Microthrombosis/endothelial injury | Thrombotic complication |
| Mask/device-related nasal dermatosis | Erosions, erythema | Pressure+irritation | Device-induced injury |
| Relapsing polychondritis | Nasal cartilage inflammation | Autoimmune chondritis | Systemic cartilage disease |
| Primary cutaneous plasmacytosis | Red-brown plaques | Plasma cell infiltration | Chronic benign course |
| Rosai–Dorfman disease | Papules/plaques | Histiocytosis (emperipolesis) | Steroid responsive |
| Erdheim–Chester disease | Xanthomatous plaques | Non-Langerhans histiocytosis | Multisystem involvement |
| Immune checkpoint inhibitor dermatitis | Lichenoid nasal plaques | Drug-induced interface dermatitis | Cancer immunotherapy complication |
| Vaccine-associated chilblain-like lesions | Violaceous nodules | Lymphocytic vasculitis | Post-vaccine self-limiting |
| Cutaneous small vessel vasculitis | Purpura/ulcers | Leukocytoclastic vasculitis | Biopsy-proven vasculitis |
| Midface toddler excoriation syndrome | Nasal/face excoriations | PRDM12 mutation | Rare genetic neuropathy |
GPA: Granulomatosis with polyangiitis, NKTCL: NK/T-cell lymphoma, LMDF: Lupus miliaris disseminatus faciei, EBV: Epstein–Barr virus

APPROACH TO A PATIENT WITH NASAL LESIONS
Detailed history
Onset and duration: Acute versus chronic, progressive versus static
Symptoms: Pain, itching, burning, bleeding, discharge, nasal obstruction
Evolution: Papule → plaque → ulcer → deformity
Triggering factors: Sun exposure, heat, alcohol, trauma, cosmetics
Systemic symptoms: Fever, weight loss, joint pain, respiratory complaints
History: Acne, rosacea, autoimmune disease, infections (TB, leprosy)
Drug history: Steroids, immunosuppressants, antiretroviral therapy
Occupational/exposure history: Travel (leishmaniasis), infections
Family history: Genodermatoses (e.g., tuberous sclerosis and Gorlin syndrome).
Clinical examination
Inspection
Site: Tip, ala, dorsum, columella, vestibule
Number: Solitary versus multiple.
-
Morphology:
Macule/papule/nodule/plaque/ulcer
Verrucous, nodular, infiltrative, telangiectatic.
-
Color:
Erythematous → inflammatory
Violaceous → granulomatous (sarcoidosis)
Pearly → basal cell carcinoma
Pigmented → melanocytic lesion.
Surface changes: scaling, crusting, ulceration, scarring
Margins: well-defined versus ill-defined.
Palpation
Consistency: Soft, firm, indurated
Tenderness
Fixity to underlying structures
Local temperature
Bleeding on touch.
Pattern recognition (clinical clues)
Centrofacial erythema + telangiectasia → rosacea
Nodular thickening of the tip → rhinophyma
Ulcer with rolled border → basal cell carcinoma
Non-healing ulcer with induration → squamous cell carcinoma
Violaceous plaque → sarcoidosis (lupus pernio)
Saddle nose deformity → vasculitis/granulomatous disease
Crusted erosions → infections (impetigo, vestibulitis).
Look for systemic associations
Malar rash → systemic lupus erythematosus
Midline destructive lesions → granulomatosis with polyangiitis
Multiple angiofibromas → tuberous sclerosis
Sebaceous tumors → Muir–Torre syndrome
Chronic ulceration → infections (leprosy, leishmaniasis, and tuberculosis).
Dermoscopic evaluation
-
Helps differentiate:
Basal cell carcinoma → arborizing vessels
Squamous cell carcinoma/actinic keratosis → keratin scale, dotted vessels
Rosacea → linear vessels.
Improves early detection of malignancy.
Laboratory and diagnostic workup
Skin biopsy – Gold standard for unclear lesions
-
Microbiological tests:
Slit-skin smear (leprosy)
Culture/smear (bacterial/fungal infections).
-
Blood tests:
Anti-nuclear antibody (systemic lupus erythematosus)
Antineutrophil cytoplasmic antibodies (vasculitis)
Angiotensin converting enzyme levels (sarcoidosis).
-
Imaging:
Computed tomography/magnetic resonance imaging for deep or destructive lesions.
Red flag signs (urgent evaluation)
Rapidly enlarging lesion
Non-healing ulcer
Bleeding or crusting lesion
Tissue destruction or deformity
Associated systemic symptoms.
Management approach
Inflammatory → topical/systemic therapy (e.g., rosacea)
Infective → targeted antimicrobial therapy
Granulomatous/systemic → multidisciplinary management
Neoplastic → biopsy + surgical excision (Mohs if needed)
Cosmetic/procedural → lasers, fillers (with caution).
Psychosocial assessment
-
Assess impact on:
Self-esteem
Social interaction.
-
Offer:
Counseling
Cosmetic correction options.
Follow-up and monitoring
-
Regular follow-up for:
Malignancy recurrence
Chronic inflammatory diseases.
-
Patient education:
Sun protection
Early reporting of new lesions.
CONCLUSION
Nasal lesions encompass a broad spectrum of dermatological conditions ranging from benign inflammatory and infectious disorders to premalignant and malignant neoplasms. Given the anatomical prominence and sun-exposed nature of the nose, careful clinical evaluation, supported by dermoscopy and histopathology when indicated, is essential for accurate diagnosis. Early recognition of suspicious features—such as ulceration, induration, telangiectasia, or non-healing lesions—plays a crucial role in timely intervention and improved outcomes. A systematic approach not only aids in differentiating benign from malignant entities but also ensures appropriate management, thereby minimizing morbidity and cosmetic disfigurement.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for their images and other clinical information to be reported in the journal. The patient understands that the patient’s names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Rosacea: current state of epidemiology. J Am Acad Dermatol. 2013;69:S27-35.
- [CrossRef] [PubMed] [Google Scholar]
- Standard classification and pathophysiology of rosacea: The 2017 update by the national rosacea society expert committee. J Am Acad Dermatol. 2018;78:148-55.
- [CrossRef] [PubMed] [Google Scholar]
- Rosacea: Part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72:749-58. quiz 759-60
- [CrossRef] [PubMed] [Google Scholar]
- Nasal fracture management: Minimizing secondary nasal deformities. Plast Reconstr Surg. 2000;106:266-73.
- [CrossRef] [PubMed] [Google Scholar]
- Vascular compromise from fillers. Dermatol Surg. 2015;41:1097-117.
- [CrossRef] [PubMed] [Google Scholar]
- Blindness following cosmetic injections of the face. Plast Reconstr Surg. 2012;129:995-1012.
- [CrossRef] [PubMed] [Google Scholar]
- Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505-20.
- [CrossRef] [PubMed] [Google Scholar]
- The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338-81.
- [CrossRef] [PubMed] [Google Scholar]
- Basal cell carcinoma: Epidemiology; Pathophysiology; Clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019;80:303-17.
- [CrossRef] [PubMed] [Google Scholar]
- Evidence-and consensus-based (S3) guidelines for the treatment of actinic keratosis-international league of dermatological societies in cooperation with the European dermatology forum-short version. J Eur Acad Dermatol Venereol. 2015;29:2069-79.
- [CrossRef] [Google Scholar]
- Tuberous sclerosis complex: Advances in diagnosis, genetics, and management. J Am Acad Dermatol. 2007;57:189-202.
- [CrossRef] [PubMed] [Google Scholar]
